AU4374696A – Inhibition of retroviral ltr promoters by calcium response modifiers
– Google Patents
AU4374696A – Inhibition of retroviral ltr promoters by calcium response modifiers
– Google Patents
Inhibition of retroviral ltr promoters by calcium response modifiers
Info
Publication number
AU4374696A
AU4374696A
AU43746/96A
AU4374696A
AU4374696A
AU 4374696 A
AU4374696 A
AU 4374696A
AU 43746/96 A
AU43746/96 A
AU 43746/96A
AU 4374696 A
AU4374696 A
AU 4374696A
AU 4374696 A
AU4374696 A
AU 4374696A
Authority
AU
Australia
Prior art keywords
inhibition
response modifiers
retroviral ltr
calcium response
ltr promoters
Prior art date
1994-12-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43746/96A
Inventor
Kevin L Gardner
Elise C Kohn
Lance A. Liotta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1994-12-12
Filing date
1995-12-06
Publication date
1996-07-03
1995-12-06
Application filed by US Department of Health and Human Services
filed
Critical
US Department of Health and Human Services
1996-07-03
Publication of AU4374696A
publication
Critical
patent/AU4374696A/en
Status
Abandoned
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/33—Heterocyclic compounds
A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
A61K31/4164—1,3-Diazoles
A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/33—Heterocyclic compounds
A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
A61K31/4192—1,2,3-Triazoles
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P31/12—Antivirals
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P31/12—Antivirals
A61P31/14—Antivirals for RNA viruses
A61P31/18—Antivirals for RNA viruses for HIV
AU43746/96A
1994-12-12
1995-12-06
Inhibition of retroviral ltr promoters by calcium response modifiers
Abandoned
AU4374696A
(en)
Applications Claiming Priority (3)
Application Number
Priority Date
Filing Date
Title
US353765
1994-12-12
US08/353,765
US6057346A
(en)
1994-12-12
1994-12-12
Inhibition of retroviral LTR promoters by calcium response modifiers
PCT/US1995/015850
WO1996018394A1
(en)
1994-12-12
1995-12-06
Inhibition of retroviral ltr promoters by calcium response modifiers
Publications (1)
Publication Number
Publication Date
AU4374696A
true
AU4374696A
(en)
1996-07-03
Family
ID=23390477
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU43746/96A
Abandoned
AU4374696A
(en)
1994-12-12
1995-12-06
Inhibition of retroviral ltr promoters by calcium response modifiers
Country Status (4)
Country
Link
US
(1)
US6057346A
(en)
EP
(1)
EP0797438A1
(en)
AU
(1)
AU4374696A
(en)
WO
(1)
WO1996018394A1
(en)
Families Citing this family (9)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
YU68701A
(en)
1999-03-26
2004-09-03
Euro-Celtique S.A.
Aryl substituted pyrazoles, imidazoles, thiazoles and pyrroles, and the use thereof
AR029489A1
(en)
2000-03-10
2003-07-02
Euro Celtique Sa
PIRIDINES, PYRIMIDINES, PIRAZINAS, TRIAZINES REPLACED BY ARILO, PHARMACEUTICAL COMPOSITIONS AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
PL214230B1
(en)
2000-03-24
2013-07-31
Euro Celtique Sa
Aryl substituted pyrazoles, triazoles and tetrazoles, and the use thereof
AR037233A1
(en)
*
2001-09-07
2004-11-03
Euro Celtique Sa
PIRIDINAS ARIL REPLACED, PHARMACEUTICAL COMPOSITIONS AND THE USE OF SUCH COMPOUNDS FOR THE PREPARATION OF A MEDICINAL PRODUCT
AR036873A1
(en)
*
2001-09-07
2004-10-13
Euro Celtique Sa
PIRIDINAS ARIL REPLACED A, PHARMACEUTICAL COMPOSITIONS AND THE USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT
AR057455A1
(en)
*
2005-07-22
2007-12-05
Merck & Co Inc
INHIBITORS OF HIV REVERSE TRANSCRIPTASE AND PHARMACEUTICAL COMPOSITION
CN101164538B
(en)
*
2006-10-16
2011-12-14
中国医学科学院基础医学研究所
Application of carboxyamido-triazoles compound and its salt in preparing medicine for treating painful diseases and/or inflammatory diseases
WO2020010003A1
(en)
2018-07-02
2020-01-09
Incyte Corporation
AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS
CN113582935A
(en)
*
2021-08-27
2021-11-02
中国医学科学院放射医学研究所
Inflammatory corpuscle nucleotide-binding oligomerization domain-like receptor protein 3 inhibitor and preparation method and application thereof
Family Cites Families (9)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US3318952A
(en)
*
1964-01-22
1967-05-09
Sandoz Ag
Dibenzylsulfamides
US4000197A
(en)
*
1973-07-23
1976-12-28
The University Of Iowa Research Foundation
Asymmetric synthesis of phenylisopropylamines
HU169507B
(en)
*
1974-09-25
1976-12-28
US4289787A
(en)
*
1977-12-19
1981-09-15
Eli Lilly And Company
Quaternary ammonium antiarrhythmic drugs
US5359078A
(en)
*
1989-05-19
1994-10-25
The United States Of America As Represented By The Department Of Health And Human Services
Signal transduction inhibitor compounds
US5132315A
(en)
*
1989-05-19
1992-07-21
The United States Of America As Represented By The Department Of Health And Human Services
Therapeutic application of an anti-invasive compound
ATE264292T1
(en)
*
1991-08-23
2004-04-15
Nps Pharma Inc
CALCIUM – RECEPTOR ACTIVE ARYLALKYLAMINS
JP2964639B2
(en)
*
1993-05-19
1999-10-18
東レ株式会社
Mixed fiber composite false twist yarn, method for producing the same, and knitted fabric using the yarn
US5631401A
(en)
*
1994-02-09
1997-05-20
Abbott Laboratories
Inhibitors of protein farnesyltransferase and squalene synthase
1994
1994-12-12
US
US08/353,765
patent/US6057346A/en
not_active
Expired – Fee Related
1995
1995-12-06
WO
PCT/US1995/015850
patent/WO1996018394A1/en
not_active
Application Discontinuation
1995-12-06
EP
EP95942561A
patent/EP0797438A1/en
not_active
Withdrawn
1995-12-06
AU
AU43746/96A
patent/AU4374696A/en
not_active
Abandoned
Also Published As
Publication number
Publication date
WO1996018394A1
(en)
1996-06-20
US6057346A
(en)
2000-05-02
EP0797438A1
(en)
1997-10-01
Similar Documents
Publication
Publication Date
Title
AU7338594A
(en)
1995-05-29
Implementation of dissolved solids profiling
AU2019295A
(en)
1995-11-30
Synthesis of microporous ceramics
AU3284395A
(en)
1996-04-04
Synthesis of 1,1,1,3,3,-pentafluoropropane
AU4538896A
(en)
1996-08-14
Laser-assisted plating of strip
AU7456396A
(en)
1997-05-22
Inhibition of amyloidosis by 9-acridinones
AU8320691A
(en)
1992-02-04
Inhibitors of retroviral proteases
AU4374696A
(en)
1996-07-03
Inhibition of retroviral ltr promoters by calcium response modifiers
AU2019195A
(en)
1995-11-30
Synthesis of microporous ceramics
AU5527196A
(en)
1996-10-23
Inhibiting retroviral replication
AU5381696A
(en)
1996-10-16
Synthesis of bis-indolylmaleimides
AU5095093A
(en)
1994-04-26
Process for the preparation of tetrazoles
ZA968550B
(en)
1998-04-14
Novel processes for the preparation of anti-malarial compounds.
AU3731595A
(en)
1996-05-23
Improved process for the preparation of 5-aminotetrazole
AU6326396A
(en)
1997-02-26
Process for the preparation of lovastatin
NO940171D0
(en)
1994-01-18
Procedure for continuous preparation of dimethoxyethane
AU6667196A
(en)
1997-03-05
Determination of chromium
AU3948395A
(en)
1996-05-06
Synthesis of 6-azaandrostenones
AU5218196A
(en)
1996-11-21
Purification of pentafluoroethane
AU1870295A
(en)
1995-08-29
Novel derivatives of tetramethylcyclopropane
EP0735080A3
(en)
1997-05-21
Process for the manufacture of sheets from starch
AU1426197A
(en)
1997-07-17
Process for the conversion of calcium sulfide
AU2061897A
(en)
1997-09-16
Separation of calcium from metal compounds
EP0781750A3
(en)
1998-03-18
Asymmetric synthesis of alpha-cycloalkylalkyl substituted methanamines
GB9518509D0
(en)
1995-11-08
Novel use of a known compound
AU3351289A
(en)
1989-10-16
Process for the construction of buildings
None